Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020

唐　榕; 施　思; 张　波; 徐　近; 王　巍

doi:10.19401/j.cnki.1007-3639.2021.01.001

您当前的位置：

首页 >

文章列表页 >

Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020

更新时间：2026-01-27

- Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020
- China Oncology Vol. 31, Issue 1, Pages: 1-10(2021)
- 作者机构：
  
  复旦大学附属肿瘤医院胰腺外科，复旦大学上海医学院肿瘤学系，复旦大学胰腺肿瘤研究所，上海市胰腺肿瘤研究所,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2021.01.001
  CLC： R735.9
- Published Online：20 February 2021，
  
  Published：20 February 2021
- 稿件说明：
移动端阅览
唐　榕, 施　思, 张　波, 徐　近, 王　巍, 虞先濬. 2020年胰腺癌研究及诊疗新进展[J]. 中国癌症杂志, 2021, 31(1): 1-10.

唐　榕, 施　思, 张　波, et al. Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020[J]. China Oncology, 2021, 31(1): 1-10.
唐　榕, 施　思, 张　波, 徐　近, 王　巍, 虞先濬. 2020年胰腺癌研究及诊疗新进展[J]. 中国癌症杂志, 2021, 31(1): 1-10. DOI： 10.19401/j.cnki.1007-3639.2021.01.001.

唐　榕, 施　思, 张　波, et al. Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020[J]. China Oncology, 2021, 31(1): 1-10. DOI： 10.19401/j.cnki.1007-3639.2021.01.001.

摘要

胰腺癌是恶性程度较高的消化道肿瘤之一，由于早期病情隐匿、疾病进展极快、化疗有效率低等原因，胰腺癌患者预后极差，5年总生存率仅约9%。近年来，随着居民饮食结构和生活方式的改变以及临床检出率的提高，胰腺癌发病率逐年升高，严重威胁居民的生命健康。大量基础研究的进展为胰腺癌的治疗提供了更多潜在靶点，高质量临床研究的成果也让更多理论上的创新和突破落到实处，这些都为胰腺癌患者预后的改善带来了新的希望。对2020年胰腺癌研究领域的重大进展进行了综述。

Abstract

Pancreatic cancer is one of the more dismal gastrointestinal tumors due to the obscure symptoms in the early stage of disease

rapid progression and insensitivity to chemotherapy. The 5-year survival rate is only approximately 9% for patients with pancreatic cancer. In the recent years

with the change in dietary structure and life style as well as the improvement of clinical detection rate

the incidence of pancreatic cancer is increasing annually

and it severely undermines the health of people. However

the advance in molecular biology provides more potential targets for the treatment of pancreatic cancer. Besides

well-conducted clinical trials continue to translate more theoretical innovations from bench to bedside. These both can improve the prognosis of pancreatic cancer eventually. The present review summarized the important findings in pancreatic cancer research in 2020.

关键词

Keywords

references

Views

3365

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

New advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2024

Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2023

New progress in basic research, clinical diagnosis and treatment of pancreatic cancer in 2022

Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2021

Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2018

Related Author

Ting WANG

Yi QIN

Xiaowu XU

Xianjun YU

Tianjiao LI

Longyun YE

Kaizhou JIN

Weiding WU

Related Institution

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai Pancreatic Cancer Institute, Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Pancreatic Cancer Institute, Fudan University

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Pancreatic Cancer Institute, Fudan University; Shanghai Pancreatic Cancer Institute

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University; Pancreatic Cancer Institute, Fudan University; Shanghai Pancreatic Cancer Institute

复旦大学附属肿瘤医院胰腺外科，复旦大学胰腺肿瘤研究所，上海市胰腺肿瘤研究所，复旦大学上海医学院肿瘤学系

AI问答

⁰